Rua Dr. Roberto Frias
4200-464 Porto
Portugal
Universidade do Porto - Centro Hospitalar
Trastuzumab; Pertuzumab; De-escalation; Pathologic complete response; FDG-PET/CT; HER2-positive; Early breast cancer